Nikki Zahl on RNAi at Invitrogen Following the Sequitur Acquisition

Oct 01, 2004

Premium

At A Glance

Name: Nikki Zahl

Position: Business segment director of RNAi

Background: Director of cloning and gene expression, Invitrogen — 2000-2003; Various product management/marketing positions, Clontech — 1995-2002; MBA, Santa Clara University — 2000; BA, political science, University of California, San Francisco — 1990

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

DNA Defense Not Convincing

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Keep on Brushing

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Panda Gut Seasonality

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

This Week in PLOS

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.

Featured White Papers

High Throughput RT-qPCR for Gene Expression Analysis

Main menu